DOCSLIB.ORG

Resverlogix Commends Dr. William Cochrane's

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Resverlogix Commends Dr. William Cochrane's For Immediate Release TSX Exchange Symbol: RVX Resverlogix Commends Dr. William Cochrane’s Induction into the Canadian Medical Hall of Fame October 26, 2009 (Calgary, AB) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) congratulates Dr. William Cochrane, OC, MD, FRCPC, FACP, DABP, Chairman of Resverlogix’s Board of Directors, who was recently announced as one of six medical pioneers inducted into the Canadian Medical Hall of Fame. Dr. Cochrane will join 76 Hall of Fame laureates who have been inducted for their work which pushed the boundaries of knowledge to advance human health. Previous appointees include Dr. Frederick Banting and Dr. Charles Best the co-founders of insulin; as well as Dr. Michael Smith for his discovery of site directed mutagenesis and Dr. Jacques Genest a preeminent researcher of the cause and treatment of high blood pressure, to name a few. Dr. Cochrane was recognized early on as a leader in pediatrics, Dr. Cochrane’s career evolved through medical research, medical education, biotechnology and business. A visionary who never gave up, Dr. Cochrane had an extraordinary ability to attract and encourage others to join him in his pursuit for excellence in Canadian medicine. As a pediatrician, Dr. Cochrane was one of the first non-hospital sub- specialists to practice in Ontario. His research interests led to the development of an acetone tolerance test to diagnose glycogen storage disease of the liver (1953) and to the Cochrane (L-leucine) test still in use today to identify a form of hypoglycemia that is sensitive to protein intake (1956). Deciding to move to Calgary Dr. Cochrane arrived with limited resources, to develop a medical school at the University of Calgary. Attracted by the opportunity to start afresh, he introduced a systems-based approach to teaching medicine and began one of only two three-year MD training programs in North America. Several successful ventures followed including becoming Alberta’s Deputy Minister of Health (1973-1974). As President of the University of Calgary (1974-1978) he established Faculties of Humanities and Law. Moving into the realm of business, as Chairman and CEO of Connaught Laboratories (1978- 1989), Dr. Cochrane championed a new strategy for the company that focused on genetic engineering. He also sat on 30 Boards of corporations ranging from biotechnology to real estate, in addition to being a dedicated community leader. Among numerous awards, Dr. Cochrane received the Order of Canada (1989), the Queens Golden Jubilee Award (2002), the Alberta Order of Excellence (2007) and was elected to the Biotechnology Hall of Fame by the BioAlberta Association (2008). He was named one of 100 Alberta Physicians of the Century (2005) and has received four honorary doctorates. His interest in helping First Nations communities earned him an honorary membership in the Stoney Indian Band (1972) and the title “Medicine Chief”. The Induction Ceremony, to be hosted for the first time in Calgary, will be held at BMO Centre on April 13, 2010. Joining Dr. Cochrane will be the other 5 inductees including Dr. Alan C. Burton MBE, Dr. Phil Gold CC OQ, Dr. James C. Hogg OC, Dr. Vera Peters OC and Dr. Calvin R. Stiller CM OOnt. The Canadian Medical Hall of Fame was created to tribute Canada’s medical pioneers who, through discovery and innovation, have contributed to better health in Canada and the world. About Resverlogix Corp. Resverlogix Corp. is a leading biotechnology company engaged in the development of novel therapies for important global medical markets with significant unmet medical needs. The NexVas™ PR program is the Company’s primary focus which is to develop novel small molecules that enhance ApoA-I. These vital therapies address the burden of atherosclerosis and other important diseases such as Acute Coronary Syndrome, Diabetes, Alzheimer’s disease, Peripheral Artery Disease and other vascular disorders. Resverlogix Corp. trades on the Toronto Stock Exchange (TSX:RVX). For further information please visit www.resverlogix.com. This news release may contain certain forward-looking statements as defined under applicable Canadian securities legislation, including our vision to be a leader in the research, development and commercialization of novel therapeutics that reduce the risk of cardiovascular disease including Page 1 of 2 atherosclerosis, diabetes, Alzheimer’s disease, Peripheral Artery Disease and other vascular diseases. These forward-looking statements contained herein that are not based on historical fact, including without limitation statements containing the words ”believes”, “anticipates”, “plans”, “intends”, “will”, “should”, “expects”, “continue”, “estimate”, “forecasts” and other similar expressions. Our actual results, events or developments could be materially different from those expressed or implied by these forward-looking statements. We can give no assurance that any of the events or expectations will occur or be realized. By their nature, forward-looking statements are subject to numerous known and unknown risks and uncertainties including but not limited to those associated with the success of research and development programs, clinical trial programs including possible delays in patient recruitment, the regulatory approval process, competition, securing and maintaining corporate alliances, market acceptance of the Company's products, the availability of government and insurance reimbursements for the Company's products, the strength of intellectual property, financing capability, the potential dilutive effects of any financing, reliance on subcontractors and key personnel and additional risk factors discussed in other documents we file from time to time with securities authorities, which are available through SEDAR at www.sedar.com. The forward-looking statements contained in this news release are expressly qualified by this cautionary statement are made as of the date hereof. The Company disclaims any intention and has no obligation or responsibility, except as required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The TSX Exchange does not accept responsibility for the adequacy or accuracy of this news release. For further information please contact: Theresa Kennedy Sarah Zapotichny VP, Corporate Communications Manager, Investor Relations Resverlogix Corp. Resverlogix Corp. Phone: 403-254-9252 Phone: 403-254-9252 Fax: 403-256-8495 Fax: 403-256-8495 Email: [email protected] Email: [email protected] Page 2 of 2 .
Load more

Recommended publications
  • James-H-Graham-Form-2020-F
    2020 - Prix du mérite James. H. Graham Date limite: le 13 septembre 2019 Ce prix du mérite a été institué en l'honneur du Dr James H. Graham, secrétaire-général du Collège royal de 1953 à 1979. Le prix est présenté à une personne dont les réalisations remarquables reflètent les buts et objectifs du Collège royal. Objectifs • Le Comité des prix et bourses du Collège royal, qui sélectionne le récipiendaire chaque année lors de sa réunion à l'automne, peut ajouter d'autres noms à la liste des candidats. • Le Comité des prix peut aussi mener sa propre recherche. • Un prix seulement sera décerné durant une année donnée. Il ne sera pas attribué nécessairement chaque année, mais sur décision du Comité des prix et bourses. Admissibilité • Il n’est pas nécessaire que cette personne soit médecin. • Le candidat ne peut poser lui-même sa candidature. • D’après les paramètres établis, les réalisations du candidat doivent être remarquables et refléter la vision, mission et les priorités stratégiques du Collège royal. La contribution des candidats, qui ne sont pas tenus d’être des médecins, pourrait être apportée dans divers domaines, notamment : • Soins aux patients • Santé/bien-être de la société • Santé internationale/mondiale • Formation médicale postdoctorale • Développement professionnel continu • Politiques de la santé • Professionnalisme/bénévolat (p.ex., bénévole du Collège royal ou d’une ANS) • Santé et bien-être des médecins/résidents • Autres domaines Le plan stratégique fournit des renseignements supplémentaires sur les priorités du Collège royal. Pour aider le Comité des prix et bourses à évaluer les mérites du candidat proposé, nous recommandons d’utiliser les lignes directrices et les documents suivants lors de la préparation et de la soumission des dossiers de candidature : • Une lettre de présentation du proposant principal justifiant la mise en candidature et décrivant la contribution du candidat.
    [Show full text]
  • Advancing Health Care
    Centre universitaire de santé McGill McGill University Health Centre Advancing Health Care Annual Report | 2 0 0 8 - 2 0 0 9 Table of Contents The Best Care for Life 1 Message from the Chairman of the Board of Directors 2 Message from the Director General and CEO 3 Vision, Mission, Values 4 Stats at a Glance 5 2008-2009 Year in Review 6-7 Clinical & Research Firsts 8-9 Advancing Health Care 10-11 Home-based care improving quality of life... 12-13 Nationwide leading pain program providing relief… 14-15 Maintaining quality of life as long as possible… 16-17 Advances in cardiac care paving bright futures… 18-19 Patient care always one step ahead… 20-21 New technology breaking down barriers… 22-23 Research 24-25 Teaching 26-27 The Redevelopment Project 28-29 Foundations 30-31 Auxiliaries & Volunteers 32-33 Awards & Honours 34-35 Board of Directors 36 Financial Results 37-40 Financial Data 41 Statistical Data 42-43 Acknowledgements 44 Annual Report 2008-2009 The Best Care For Life The McGill University Health Centre (MUHC) is a comprehensive academic health institution with an international reputation for excellence in clinical programs, research and teaching. Its partner hospitals are the Montreal Children’s, the Montreal General, the Royal Victoria, the Montreal Neurological Hospital/Institute, the Montreal Chest Institute as well as the Lachine Hospital and Camille- Lefebvre Pavillion. Building on our tradition of medical leadership, the MUHC continues to shape the course of academic medicine by attracting clinical and research authorities from around the world, by training the next generation of medical professionals, and continuing to provide the best care for life to people of all ages.
    [Show full text]
  • Il Est Un Petit Honneur «Qui Fait Grand Plaisir!» Michèle Thibodeau-Deguire a Accédé À L’Académie Des Grands Montréalais En 2001
    LE DEVOIR, LE MERCREDI 16 NOVEMBRE 2011 MONTREAL CAHIER C LES GRANDS MONTRÉALAIS Sid Stevens Frédéric Back Pierre Fortin est le Grand Montréalais devient à 87 ans et Aldo Bensadoun en 2011 le Grand Mont- rejoignent du secteur social réalais culturel la communauté Page 3 Page 5 Pages 4 et 6 JACQUES NADEAU LE DEVOIR Centraide encourage le développement du réseau des intervenants au sein de chaque quartier de Montréal. Il est un petit honneur «qui fait grand plaisir!» Michèle Thibodeau-DeGuire a accédé à l’Académie des Grands Montréalais en 2001 En 2001, Michèle Thibodeau-DeGuire, présidente et directri- police, l’école, les organismes communautaires, le CLSC, etc., ce générale de Centraide du Grand Montréal, s’est vu décer- travaillent dans le même sens ner le titre de Grand Montréalais, un honneur qui lui a fait pour trouver des solutions avec réellement plaisir. «C’est très, très, très excitant, lance tout à les citoyens, indique Mme Thi- fait joyeusement cette Acadienne de souche. C’est probable- bodeau-DeGuire. Nous finan- çons donc des tables de concerta- ment même, de tous les honneurs que j’ai reçus, celui qui tion depuis près de vingt ans, m’a le plus touchée!» afin de réunir les divers interve- nants pour qu’ils s’entendent sur CLAUDE LAFLEUR l’un ou l’autre des quatre les priorités de leur quartier. La champs d’activité — écono- table réunit ceux qui possèdent ela m’a même mique, social, culturel et une partie de la solution, ce qui surprise, se scientifique. Il y a ensuite un a déjà tout un impact.» « souvient Mi- petit groupe qui se réunit chèle Thibo- pour établir une courte liste 2011 sera deau-DeGuire, — trois ou quatre noms par une bonne année nomméeC «Grande Montréalai- secteur d’activité.
    [Show full text]
  • Breast Density What Are the Implications for Cancer Screening?
    2018 ISSUE 2 Breast Density What are the implications for cancer screening? Key Concepts Fever in children returning from travel Choose Wisely Deciding on tests and treatments using the evidence base is Proud to celebrate 10 YEARS in Canada 42 million patients treated in clinical practice worldwide across all indications1 Thank you for your partnership over the last 10 years. We look forward to many more. Xarelto® is indicated for treatment of venous thromboembolic events For the treatment of VTE, Xarelto® is not recommended as an alternative (deep vein thrombosis [DVT], pulmonary embolism [PE]) and prevention to unfractionated heparin in patients with acute pulmonary embolus of recurrent DVT and PE. who are haemodynamically unstable, or who may receive thrombolysis or pulmonary embolectomy, since the safety and effi cacy of Xarelto® Xarelto® is indicated for the prevention of stroke and systemic have not been established in these clinical situations. embolism in patients with atrial fi brillation, in whom anticoagulation is appropriate. Xarelto® is not recommended for use in children less than 18 years of age. Xarelto® is indicated for the prevention of venous thromboembolic Consult the Xarelto® Product Monograph at http://bayer.ca/xarelto events (VTE) in patients who have undergone elective total hip for contraindications, warnings, precautions, adverse reactions, replacement (THR) or total knee replacement (TKR) surgery. interactions, dosing, and conditions of clinical use. The Product Monograph is also available by calling 1-800-265-7382. References: 1. Bayer data on fi le. 2. Xarelto® (rivaroxaban tablet) Product Monograph. Bayer Inc. May 9, 2018. ® TM see www.bayer.ca/tm-mc © 2018, Bayer Inc.
    [Show full text]
  • Radiation Medicine Program
    Radiation Medicine Program ANNUAL 2020 REPORT 2021 VALUES MISSION Innovation Advance exemplary radiation Excellence medicine through patient Collaboration care, research & education Accountability in partnership with CONTENTS Integrity our patients & community 4 A Message from the Chief 6 Program Overview 7 2020: The Year in Numbers 8 Strategic Roadmap to 2026 VISION 10 Clinical Care CURE EVOLVE 15 Quality & Safety Predictive Health & Precision Radiation Medicine. Advanced Particle Adaptive Radiotherapy Therapy & Theranostics 18 Education Personalized Care. 21 Research Global Impact. 26 Team RMP COMFORT & CONNECT Systems to Maximize CONFIDENCE Innovation & Wellbeing Technology-enabled Patient Experience Transformation A MESSAGE FROM THE CHIEF The Radiation Medicine Program (RMP) at the Princess Margaret Cancer Centre is committed to delivering the highest standard of patient care. Over the RMP’s innovative education programs continue to thrive and attract a diverse group of national and international attendees. Our award-winning Accelerated past year, our dynamic multidisciplinary team of radiation oncologists, medical physicists, radiation therapists, administrators, and support staff have worked Education Program (AEP) demonstrated extraordinary resourcefulness this past year, standing strong amidst the pandemic, and continuing to provide top- together to advance our vision of “Precision Radiation Medicine. Personalized Care. Global Impact.” RMP continues to uphold our foundational values of level education to a broad spectrum of learners.
    [Show full text]
  • Recollections of the History of Neuropsychopharmacology Through Interviews Conducted by William E. Bunney, Jr
    1 RECOLLECTIONS OF THE HISTORY OF NEUROPSYCHOPHARMACOLOGY THROUGH INTERVIEWS CONDUCTED BY WILLIAM E. BUNNEY, JR. Edited by Peter R. Martin International Network for the History of Neuropsychopharmacology Risskov 2016 2 William E. Bunney, Jr. (circa 1980) 3 Contents PREFACE ..................................................................................................................................................... 4 1. THOMAS A. BAN ............................................................................................................................... 9 2. ARVID CARLSSON .......................................................................................................................... 28 3. JOSEPH T. COYLE ............................................................................................................................ 38 4. ELLEN FRANK ................................................................................................................................. 55 5. J. CHRISTIAN GILLIN ..................................................................................................................... 66 6. LOUIS A. GOTTSCHALK ................................................................................................................ 78 7. SALOMON Z. LANGER ................................................................................................................... 89 8. HEINZ E. LEHMANN ....................................................................................................................
    [Show full text]
  • Faculty of Medicine Programs, Courses and University Regulations 2017-2018
    Faculty of Medicine Programs, Courses and University Regulations 2017-2018 This PDF excerpt of Programs, Courses and University Regulations is an archived snapshot of the web content on the date that appears in the footer of the PDF. Archival copies are available at www.mcgill.ca/study. This publication provides guidance to prospects, applicants, students, faculty and staff. 1 . McGill University reserves the right to make changes to the information contained in this online publication - including correcting errors, altering fees, schedules of admission, and credit requirements, and revising or cancelling particular courses or programs - without prior notice. 2 . In the interpretation of academic regulations, the Senate is the ®nal authority. 3 . Students are responsible for informing themselves of the University©s procedures, policies and regulations, and the speci®c requirements associated with the degree, diploma, or certi®cate sought. 4 . All students registered at McGill University are considered to have agreed to act in accordance with the University procedures, policies and regulations. 5 . Although advice is readily available on request, the responsibility of selecting the appropriate courses for graduation must ultimately rest with the student. 6 . Not all courses are offered every year and changes can be made after publication. Always check the Minerva Class Schedule link at https://horizon.mcgill.ca/pban1/bwckschd.p_disp_dyn_sched for the most up-to-date information on whether a course is offered. 7 . The academic publication year begins at the start of the Fall semester and extends through to the end of the Winter semester of any given year. Students who begin study at any point within this period are governed by the regulations in the publication which came into effect at the start of the Fall semester.
    [Show full text]
  • Details September 2020, No. 5
    SEPTEMBER 2020 | No. 5 Details Your source for new Canadian stamps DEAR COLLECTORS COMING SOON! We care about your well-being At Canada Post, our priority during these challenging Don’t miss times continues to be the safety and health of our customers, employees and communities, while we a single issue work to provide Canadians with the essential services they depend on. Some of the temporary changes Check out our preview list made to the stamp program and the way we distribute and on-sale dates below and new issues to postal outlets remain in effect until further notice. Be sure to order your stamps online at mark your calendar. Then visit canadapost.ca/shop, so you don’t miss out. canadapost.ca to add these soon-to-be-released issues to Other changes have been made over the short term: your collection. • Print versions of Details special edition (Nos. 3 and 4) and No. 5 were sent to subscribers and are available online. Diwali • Stamp unveiling events will proceed in a virtual format. In-person events remain suspended until October 15 further notice. Mary Riter Hamilton This issue of Details features our Medical Groundbreakers October 28 stamps, highlighting six physicians and researchers whose innovative work is more evidence why Canada is a Holiday: Maud Lewis global leader in medical research and treatments that November 2 change lives. We’re also revealing our annual fundraising stamp for the Canada Post Community Foundation. The Christmas: The Nativity purchase of the stamp allows our customers to contrib- ute directly to grassroots and community programs that November 2 benefit Canadian children and youth – initiatives that need our support now more than ever.
    [Show full text]
  • Vancouver Institute: an Experiment in Public Education
    1 2 The Vancouver Institute: An Experiment in Public Education edited by Peter N. Nemetz JBA Press University of British Columbia Vancouver, B.C. Canada V6T 1Z2 1998 3 To my parents, Bel Newman Nemetz, B.A., L.L.D., 1915-1991 (Pro- gram Chairman, The Vancouver Institute, 1973-1990) and Nathan T. Nemetz, C.C., O.B.C., Q.C., B.A., L.L.D., 1913-1997 (President, The Vancouver Institute, 1960-61), lifelong adherents to Albert Einstein’s Credo: “The striving after knowledge for its own sake, the love of justice verging on fanaticism, and the quest for personal in- dependence ...”. 4 TABLE OF CONTENTS INTRODUCTION: 9 Peter N. Nemetz The Vancouver Institute: An Experiment in Public Education 1. Professor Carol Shields, O.C., Writer, Winnipeg 36 MAKING WORDS / FINDING STORIES 2. Professor Stanley Coren, Department of Psychology, UBC 54 DOGS AND PEOPLE: THE HISTORY AND PSYCHOLOGY OF A RELATIONSHIP 3. Professor Wayson Choy, Author and Novelist, Toronto 92 THE IMPORTANCE OF STORY: THE HUNGER FOR PERSONAL NARRATIVE 4. Professor Heribert Adam, Department of Sociology and 108 Anthropology, Simon Fraser University CONTRADICTIONS OF LIBERATION: TRUTH, JUSTICE AND RECONCILIATION IN SOUTH AFRICA 5. Professor Harry Arthurs, O.C., Faculty of Law, Osgoode 132 Hall, York University GLOBALIZATION AND ITS DISCONTENTS 6. Professor David Kennedy, Department of History, 154 Stanford University IMMIGRATION: WHAT THE U.S. CAN LEARN FROM CANADA 7. Professor Larry Cuban, School of Education, Stanford 172 University WHAT ARE GOOD SCHOOLS, AND WHY ARE THEY SO HARD TO GET? 5 8. Mr. William Thorsell, Editor-in-Chief, The Globe and 192 Mail GOOD NEWS, BAD NEWS: POWER IN CANADIAN MEDIA AND POLITICS 9.
    [Show full text]
  • Leblond to Hermo
    History 6 - Leblond to Hermo Summary of Topics 47. Charles Philippe Leblond (McGill: 1941-2007) – p 2 48. The C.P. Leblond Celebratory Symposium (2011) – p 14 49. The Second World War (1939-1945) – p 15 50. Stanley Martin Banfill (McGill: 1946-1971) – p 16 51. Yves Wilfrid Clermont (McGill: 1953-1998) – p 17 52. Norman J. Nadler (McGill: 1953-1997) – p 21 53. Beatrix Kopriwa (McGill: 1958-1978) and the Radioautography Facility – p 23 54. Hershey Warshawsky (McGill: 1959-2013) – p 24 55. Dennis G. Osmond (McGill: 1965-2016) – p 26 56. S. Carl Harvey (McGill: 1966-1973) – p 31 57. Peyush Lala (McGill: 1969-1984) – p 32 58. Bernard Droz, Alain Rambourg and the French Connection – p 33 59. Antonio Haddad and the Brazilian Connection – p 34 60. Annette Herscovics (McGill: 1969-1974) – p 35 61. Gary Bennett (McGill: 1970-2014) – p 36 62. Eugene Daniels (McGill: 1971- ) – p 37 63. Michael F. Lalli (McGill: 1971- ) – p 39 64. Charles E. Smith (McGill: 1971- ) – p 40 65. A Brief History of Electron Microscopy - p 41 66. Our Departmental Electron Microscope Laboratory – p 44 67. John J. M. Bergeron (McGill: 1974-2010) – p 46 1 68. Sandra Miller (McGill: 1975-2014) – p 50 69. Louis Hermo (McGill: 1977-2016) – p 52 ________________________________________________________________________ 47. Charles Philippe Leblond (McGill: 1941-2007) C.P. Leblond NOTE: Much of the material in the following section is taken from an article by the author in Biographical Memoirs of Fellows of the Royal Society. 54: 175-191 (2008) in which references are found Bennett 2.
    [Show full text]
  • On the Front Lines of Mental Health
    WINTER 2014 UNIVERSITY OF TORONTO MEDICAL ALUMNI ASSOCIATION MAGAZINE MAAMATTERS ON THE FRONT LINES OF MENTAL HEALTH ConvoCation 2014 • FivE DECaDES DiFFEREnt? TO COME DEAN’S MESSAGE Dr. CaTharine WhiTesiDe (1975) A farewell message The Medical Alumni Association (MAA) to provide opportunities to help build at the University of Toronto is one of our and sustain this valued relationship. most important organizations for the When students and trainees enter our ongoing and future success of our medical MD and postgraduate programs, we school. As I complete my tenure as the welcome them into the U of T medical Dean of Medicine and look back over my school family and make a tremendous years closely associated with the MAA, I am effort enabling them to fulfill their HY P very proud of the dedication and accom- potential. Once they graduate they should RA G plishments of our alumni and the MAA feel part of our extended family that now Board. Last year the Faculty established reaches into every aspect of the Canadian PHOTO L E three alumni awards, including the Alumni health system and beyond. We must NN O D Volunteer Award, the Lifetime Achievement provide support for their continuing Award and the Rising Star Award. The professional development, access to rapidly HY: MAC HY: P MAA also recognizes alumni contributions expanding knowledge and its application, RA G through awards and scholarships. and we must welcome their engagement It is so important that we recognize in the mentoring and teaching of our PHOTO alumni who have made an impact through students and trainees.
    [Show full text]
  • Killam Prizes | Prix Killam
    Killam Prizes | Prix Killam Year | Winners | University | Discipline Année Gagnants Université 2021 Michel Bouvier Université de Montréal Health Sciences | sciences de la santé Stephen R. Gill York University Social Sciences | sciences sociales Gilbert Laporte HEC Montréal Engineering | génie Arthur Ripstein University of Toronto Humanities | sciences humaines Douglas Stephan University of Toronto Natural Sciences | sciences de la nature 2020 Cecilia Benoit University of Victoria Social Sciences | sciences sociales Sarah Carter University of Alberta Humanities | sciences humaines Alan Evans Montreal Neurological Institute Health Sciences | sciences de la santé Ted Sargent University of Toronto Engineering | génie Barbara Sherwood Lollar University of Toronto Natural Sciences | sciences de la nature 2019 Yoshua Bengio Université de Montréal Natural Sciences | sciences de la nature André Blais Université de Montréal Social Sciences | sciences sociales Keith W. Hipel University of Waterloo Engineering | génie Stephen W. Scherer University of Toronto Health Sciences | sciences de la santé Lynne Viola University of Toronto Humanities | sciences humaines 2018 André Gaudreault Université de Montréal Humanities | sciences humaines Vladimir Hachinski Western University Health Sciences | sciences de la santé Walter Herzog University of Calgary Engineering | génie James Pinfold University of Alberta Natural Sciences | sciences de la nature Janet Werker University of British Columbia Social Sciences | sciences sociales Canada Council for the Arts
    [Show full text]